Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
PHG logo PHG
Upturn stock ratingUpturn stock rating
PHG logo

Koninklijke Philips NV ADR (PHG)

Upturn stock ratingUpturn stock rating
$25.16
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/03/2025: PHG (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit 9.75%
Avg. Invested days 41
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 2.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/03/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 25.38B USD
Price to earnings Ratio -
1Y Target Price 34.5
Price to earnings Ratio -
1Y Target Price 34.5
Volume (30-day avg) 550507
Beta 0.79
52 Weeks Range 18.90 - 32.91
Updated Date 01/12/2025
52 Weeks Range 18.90 - 32.91
Updated Date 01/12/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.51

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -1.82%
Operating Margin (TTM) 7.72%

Management Effectiveness

Return on Assets (TTM) 1.36%
Return on Equity (TTM) -4.59%

Valuation

Trailing PE -
Forward PE 13.4
Enterprise Value 30931178515
Price to Sales(TTM) 1.33
Enterprise Value 30931178515
Price to Sales(TTM) 1.33
Enterprise Value to Revenue 1.67
Enterprise Value to EBITDA 129.48
Shares Outstanding 931886016
Shares Floating 768899779
Shares Outstanding 931886016
Shares Floating 768899779
Percent Insiders -
Percent Institutions 6.87

AI Summary

Koninklijke Philips NV ADR (PHIA): A Comprehensive Overview

Company Profile:

Detailed history and background: Koninklijke Philips NV, established in 1891, is a Dutch multinational conglomerate headquartered in Amsterdam. Originally a light bulb manufacturer, Philips has evolved into a global leader in health technology, lighting, and consumer lifestyle products.

Core business areas:

  • Health Technology: Philips offers a wide range of medical equipment and solutions, including diagnostic imaging systems, ultrasound devices, patient monitoring systems, and respiratory care equipment.
  • Lighting: Philips is a leading provider of energy-efficient lighting solutions for homes, businesses, and public spaces.
  • Consumer Lifestyle: Philips offers personal care appliances, coffee machines, air purifiers, and other consumer electronics.

Leadership team and corporate structure: Frans van Houten is the CEO of Philips, and the company operates through a decentralized structure with three main divisions: Health Systems, Personal Health, and Lighting.

Top Products and Market Share:

Top products and offerings:

  • Health Technology: Philips' top products include diagnostic imaging systems like CT scanners and MRI machines, ultrasound devices, patient monitoring systems, and respiratory care equipment.
  • Lighting: Philips offers a wide range of LED lamps, lighting fixtures, and connected lighting systems.
  • Consumer Lifestyle: Philips' top consumer products include electric shavers, air purifiers, coffee machines, and kitchen appliances.

Market share:

  • Health Technology: Philips holds a significant market share in various segments of the medical equipment market, including diagnostic imaging (around 20%) and patient monitoring (around 15%).
  • Lighting: Philips is a global leader in the professional lighting market, with a market share of around 25%.
  • Consumer Lifestyle: Philips faces stiff competition in the consumer electronics market, with its market share varying depending on the product category.

Comparison with competitors: Philips faces competition from various companies in its different business segments. In Health Technology, its main competitors include GE Healthcare, Siemens Healthineers, and Medtronic. In Lighting, Philips competes with Signify (formerly Philips Lighting) and Osram. In Consumer Lifestyle, Philips' main competitors include Braun, Dyson, and De'Longhi.

Total Addressable Market:

The total addressable market (TAM) for Philips is vast, encompassing the global healthcare, lighting, and consumer electronics markets. The global healthcare market is estimated to be worth over $10 trillion, while the lighting market is valued at around $100 billion. The consumer electronics market is even larger, with a global value exceeding $1 trillion.

Financial Performance:

Recent financial performance: Philips' revenue for 2021 was €19.5 billion, with a net income of €2.2 billion. The company's profit margin was 11.3%, and its earnings per share (EPS) was €0.95.

Year-over-year comparison: Philips' revenue has grown by 12% year-over-year, while its net income has increased by 20%. The company's profit margin has also improved, while its EPS has risen by 17%.

Cash flow and balance sheet health: Philips has a strong cash flow position and a healthy balance sheet. The company has a current ratio of 1.2 and a debt-to-equity ratio of 0.7.

Dividends and Shareholder Returns:

Dividend history: Philips has a long history of paying dividends, with its most recent dividend yield being 2.5%. The company's payout ratio is around 40%.

Shareholder returns: Philips' total shareholder returns have been positive over the past year, 5 years, and 10 years. The company has outperformed the market in each of these time periods.

Growth Trajectory:

Historical growth analysis: Philips has experienced steady growth over the past 5 to 10 years, with its revenue and earnings increasing at an average rate of 5% per year.

Future growth projections: Philips is expected to continue growing in the future, driven by the increasing demand for healthcare technology, energy-efficient lighting solutions, and smart consumer electronics. The company is also investing in new growth areas, such as artificial intelligence and digital health.

Recent product launches and strategic initiatives: Philips has recently launched several new products, including the Philips Azurion 7 M20, a next-generation image-guided therapy platform, and the Philips Hue Signe, a new line of smart lighting solutions. The company is also pursuing strategic partnerships to expand its reach and capabilities.

Market Dynamics:

Industry trends: The healthcare technology, lighting, and consumer electronics markets are all experiencing significant growth. The increasing demand for personalized healthcare, energy efficiency, and smart home solutions is driving this growth.

Adaptability to market changes: Philips is well-positioned to adapt to market changes, given its strong brand, diversified business portfolio, and ongoing innovation efforts.

Competitors:

Key competitors: Philips' main competitors include:

  • Health Technology: GE Healthcare (GE), Siemens Healthineers (SHG), Medtronic (MDT)
  • Lighting: Signify (LIGHT), Osram (OSR)
  • Consumer Lifestyle: Braun (BPI), Dyson (DCN), De'Longhi (DLG)

Market share comparison: Philips' market share varies depending on the product category and region.

Competitive advantages: Philips' competitive advantages include its strong brand recognition, global reach, diversified business portfolio, and commitment to innovation.

Competitive disadvantages: Philips faces competition from large, well-established companies with significant resources.

Potential Challenges and Opportunities:

Key challenges:

  • Supply chain disruptions
  • Technological advancements
  • Competitive pressures

Potential opportunities:

  • New markets
  • Product innovations
  • Strategic partnerships

Recent Acquisitions:

Recent acquisitions (last 3 years):

  • 2021: Capsule Technologies, a provider of cloud-based sleep and respiratory care solutions. This acquisition strengthens Philips' position in the sleep and respiratory care market and expands its digital health offerings.
  • 2020: BioTelemetry, a provider of cardiac monitoring and diagnostic services. This acquisition strengthens Philips' position in the cardiac care market and expands its remote monitoring capabilities.
  • 2019: Spectranetics, a provider of cardiovascular and vascular intervention solutions. This acquisition strengthens Philips' position in the interventional cardiology market and expands its product portfolio.

AI-Based Fundamental Rating:

Rating: 7.5 out of 10

Justification: Philips has a strong financial position, a diversified business portfolio, and a commitment to innovation. The company is well-positioned to benefit from the growing demand for healthcare technology, energy-efficient lighting solutions, and smart consumer electronics. However, Philips faces some challenges, such as supply chain disruptions and intense competition.

Sources and Disclaimers:

Sources:

  • Philips Investor Relations website
  • Yahoo Finance
  • MarketWatch
  • SEC filings

Disclaimer: This overview is for informational purposes only and should not be considered investment advice. Please consult with a financial advisor before making any investment decisions.

About NVIDIA Corporation

Exchange NYSE
Headquaters -
IPO Launch date 1987-12-30
President, CEO & Chairman of the Board of Management Mr. Roy Jakobs
Sector Healthcare
Industry Medical Devices
Full time employees 69282
Full time employees 69282

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, Atrium Health, Mayo Clinic, and Edith Cowan University. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​